IRIS Accounts Production v26.1.0.640 07045043 director 1.2.25 31.1.26 31.1.26 true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070450432025-01-31070450432026-01-31070450432025-02-012026-01-31070450432024-01-31070450432024-02-012025-01-31070450432025-01-3107045043ns15:EnglandWales2025-02-012026-01-3107045043ns14:PoundSterling2025-02-012026-01-3107045043ns10:Director12025-02-012026-01-3107045043ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3107045043ns10:SmallEntities2025-02-012026-01-3107045043ns10:AuditExemptWithAccountantsReport2025-02-012026-01-3107045043ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3107045043ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3107045043ns10:FullAccounts2025-02-012026-01-3107045043ns10:OrdinaryShareClass12025-02-012026-01-3107045043ns10:CompanySecretary12025-02-012026-01-3107045043ns10:RegisteredOffice2025-02-012026-01-3107045043ns5:CurrentFinancialInstruments2026-01-3107045043ns5:CurrentFinancialInstruments2025-01-3107045043ns5:ShareCapital2026-01-3107045043ns5:ShareCapital2025-01-3107045043ns5:FurtherSpecificReserve3ComponentTotalEquity2026-01-3107045043ns5:FurtherSpecificReserve3ComponentTotalEquity2025-01-3107045043ns5:FurnitureFittings2025-02-012026-01-3107045043ns5:ComputerEquipment2025-02-012026-01-3107045043ns5:FurnitureFittings2025-01-3107045043ns5:ComputerEquipment2025-01-3107045043ns5:FurnitureFittings2026-01-3107045043ns5:ComputerEquipment2026-01-3107045043ns5:FurnitureFittings2025-01-3107045043ns5:ComputerEquipment2025-01-3107045043ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3107045043ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3107045043ns10:OrdinaryShareClass12026-01-3107045043ns10:Director112025-01-3107045043ns10:Director112024-01-3107045043ns10:Director112025-02-012026-01-3107045043ns10:Director112024-02-012025-01-3107045043ns10:Director112026-01-3107045043ns10:Director112025-01-31
REGISTERED NUMBER: 07045043 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026

FOR

P B CLINICAL SERVICES LIMITED

P B CLINICAL SERVICES LIMITED (REGISTERED NUMBER: 07045043)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Report of the Accountants 6

P B CLINICAL SERVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2026







DIRECTOR: Mrs P H Bedwell





SECRETARY: M J Bedwell





REGISTERED OFFICE: 45 Queen Street
Deal
Kent
CT14 6EY





REGISTERED NUMBER: 07045043 (England and Wales)





ACCOUNTANTS: Higson & Co (Deal) Ltd
45 Queen Street
Deal
Kent
CT14 6EY

P B CLINICAL SERVICES LIMITED (REGISTERED NUMBER: 07045043)

BALANCE SHEET
31 JANUARY 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 199 265

CURRENT ASSETS
Debtors 5 110,258 112,808
Cash at bank 2,791 1,633
113,049 114,441
CREDITORS
Amounts falling due within one year 6 34,418 38,559
NET CURRENT ASSETS 78,631 75,882
TOTAL ASSETS LESS CURRENT
LIABILITIES

78,830

76,147

CAPITAL AND RESERVES
Called up share capital 7 1,000 1,000
Fair value reserve - 8,039
Retained earnings 77,830 67,108
SHAREHOLDERS' FUNDS 78,830 76,147

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 April 2026 and were signed by:





Mrs P H Bedwell - Director


P B CLINICAL SERVICES LIMITED (REGISTERED NUMBER: 07045043)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

1. STATUTORY INFORMATION

P B Clinical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in round pounds £ sterling.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
Pension costs are represented by Company contributions into the Director's personal pension fund.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 1 ) .

P B CLINICAL SERVICES LIMITED (REGISTERED NUMBER: 07045043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 February 2025
and 31 January 2026 3,680 266 3,946
DEPRECIATION
At 1 February 2025 3,516 165 3,681
Charge for year 41 25 66
At 31 January 2026 3,557 190 3,747
NET BOOK VALUE
At 31 January 2026 123 76 199
At 31 January 2025 164 101 265

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Amounts owed by group undertakings 110,258 112,754
Other debtors - 54
110,258 112,808

The amount owed by group undertakings is represented by a loan made to the subsidiary company, Micaze Properties Limited. Interest is payable at 5% per annum and the loan is repayable on demand. At the year end, the loan and accrued interest were repayable in full.

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Tax 624 1,879
Other creditors 32,600 32,600
Directors' current accounts 534 3,479
Accrued expenses 660 601
34,418 38,559

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
1,000 Ordinary £1 1,000 1,000

P B CLINICAL SERVICES LIMITED (REGISTERED NUMBER: 07045043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2026 and 31 January 2025:

2026 2025
£    £   
Mrs P H Bedwell
Balance outstanding at start of year 3,479 28,507
Amounts advanced (3,279 ) (41,840 )
Amounts repaid 334 16,812
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 534 3,479

P B CLINICAL SERVICES LIMITED

REPORT OF THE ACCOUNTANTS TO THE DIRECTOR OF
P B CLINICAL SERVICES LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 January 2026 set out on pages one to nine and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Higson & Co (Deal) Ltd
45 Queen Street
Deal
Kent
CT14 6EY


Date: .............................................